Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10q0618ex31-2_citiuspharma.htm |
| EX-31.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10q0618ex31-1_citiuspharma.htm |
| 10-Q - QUARTERLY REPORT - Citius Pharmaceuticals, Inc. | f10q0618_citiuspharma.htm |
EXHIBIT 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
AND THE CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Citius Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Myron Holubiak, Chief Executive Officer of the Company, and Jaime Bartushak, Chief Financial Officer of the Company certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: August 14, 2018 | By: | /s/ Myron Holubiak |
| Myron Holubiak | ||
| Chief Executive Officer, | ||
| (Principal Executive Officer) | ||
| Date: August 14, 2018 | By: | /s/ Jaime Bartushak |
| Jaime Bartushak | ||
| Chief Financial Officer | ||
| (Principal Financial and Accounting Officer) |